|
|
|
Volumn 10, Issue 10, 2007, Pages 686-689
|
|
Antibody World Summit 2007 - SRI's sixth annual meeting - Discovery & development/manufacturing & processing
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY 3F2 3M;
ANTIBODY HUN901;
ANTIGEN;
AURISTATIN F ANTIBODY;
CYTOTOXIC AGENT;
DNA;
DNA BINDING PROTEIN;
EPHRIN A2;
LEXATUMUMAB;
MAYTANSINOID;
MONOCLONAL ANTIBODY;
TRASTUZUMAB;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
UNCLASSIFIED DRUG;
ZINC FINGER PROTEIN;
ANTIBODY DETECTION;
ANTIBODY SPECIFICITY;
BINDING AFFINITY;
BREAST CANCER;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONFERENCE PAPER;
DNA SEQUENCE;
DNA STRAND BREAKAGE;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG RESEARCH;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG STABILITY;
DRUG TARGETING;
ESOPHAGUS CANCER;
HUMAN;
IMMUNOTHERAPY;
LUNG SMALL CELL CANCER;
NONHUMAN;
OVARY CANCER;
PROTEIN STRUCTURE;
ANIMALS;
ANTIBODIES;
CLINICAL TRIALS AS TOPIC;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
DRUGS, INVESTIGATIONAL;
HUMANS;
NEOPLASMS;
SYSTEMS BIOLOGY;
TECHNOLOGY, PHARMACEUTICAL;
VIRUS DISEASES;
|
|
EID: 34748817981
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
